Abstract

People in artisanal and small-scale gold mining (ASGM) areas are frequently exposed to high levels of mercury (Hg). Hg analyses in urine and whole blood are the gold standard of biomonitoring, although this may not provide sufficient information about the source of exposure, e.g., due to the use of Hg for gold extraction or due to nutrition. To evaluate, whether the pharmacokinetic properties of individual Hg species may be useful for exposure assessment, we determined the Hg levels in different blood components from 199 participants. Therefore, whole blood was centrifuged on-site to yield erythrocytes and plasma. Globin was isolated from the erythrocytes by precipitation with ethyl acetate. Albumin was isolated from plasma by gradual precipitation with saturated ammonium sulfate solution. Hg levels in all samples were determined by using a direct Hg analyzer. Median Hg levels for whole blood, erythrocytes, and plasma were 2.7, 3.7, and 1.3 μg/l, respectively. In globin and albumin, median Hg levels were 10.3 and 7.9 μg/kg, respectively. The distribution of Hg was strongly correlated with whole blood Hg levels (p < 0.01) and the time between the last use of Hg and the date of the participation (p < 0.01). The results suggest that the distribution of Hg in blood is substantially affected by the extent and the frequency of the exposure to elemental Hg. Therefore, the analysis of Hg in erythrocytes and plasma may be a valuable tool for Hg exposure assessment in ASGM areas.

Highlights

  • Despite its international condemnation, mercury (Hg) is still heavily used in artisanal and small-scale gold mining (ASGM), which accounts for approximately 38 % of the global annual high levels of mercury (Hg) emissions [1]

  • Hg levels in erythrocytes, plasma, globin, and albumin have never been analyzed far in individuals living and working in ASGM areas

  • This indicates that the isolated proteins resemble the Hg levels in erythrocytes and plasma, respectively

Read more

Summary

Introduction

Mercury (Hg) is still heavily used in artisanal and small-scale gold mining (ASGM), which accounts for approximately 38 % of the global annual Hg emissions [1]. Amalgamation of gold remains the primary method of choice in ASGM. 10 to 19 million people are involved, threatened by serious health consequences due to acute and chronic Hg exposure [2,3,4,5]. The primary exposure pathway in ASGM is the inhalation of elemental Hg, which is primarily released during amalgam smelting. Amalgam smelters had a significantly higher Hg body burden compared to gold panners or the general population living in ASGM areas [1].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call